| P2093 | author name string | Chau-Ting Yeh | |
| | Tse-Ching Chen | |
| | Ta-Sen Yeh | |
| | Tong-Hong Wang | |
| | Yu-Ling Wang | |
| | Kung-Hao Liang | |
| | Kwai-Fong Ng | |
| P2860 | cites work | Antisense oligodeoxynucleotides of IGF-II selectively inhibit growth of human hepatoma cells overproducing IGF-II. | Q53438893 |
| | Down-regulation of ephrin-A5, a gene product of normal cartilage, in chondrosarcoma. | Q54468625 |
| | Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study | Q80834248 |
| | Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis | Q84595305 |
| | Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling | Q24292382 |
| | Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling | Q28258431 |
| | Ephrins and Eph receptors in stem cells and cancer | Q28292229 |
| | Ephrin-A5 and EphA5 Interaction Induces Synaptogenesis during Early Hippocampal Development | Q28574096 |
| | The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide | Q29616215 |
| | Eph-ephrin bidirectional signaling in physiology and disease | Q29617975 |
| | Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen | Q33195738 |
| | Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia | Q33754623 |
| | Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma | Q33947429 |
| | Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers | Q34290211 |
| | Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma | Q34842280 |
| | c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma | Q35235798 |
| | Cancer immunology--analysis of host and tumor factors for personalized medicine | Q35583180 |
| | Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less | Q35598182 |
| | Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis | Q35676765 |
| | Current status of hepatic resection for hepatocellular carcinoma | Q35953443 |
| | Hepatocellular carcinoma: epidemiology, risk factors, and screening | Q36140282 |
| | Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice | Q36326357 |
| | Bidirectional ephrin/Eph signaling in synaptic functions | Q36682364 |
| | Cell-cell signaling via Eph receptors and ephrins | Q36967529 |
| | Eph receptors and Ephrins in cancer: common themes and controversies. | Q37020858 |
| | Eph/ephrin signaling: networks. | Q37087056 |
| | The Eph receptor/ephrin system: an emerging player in the invasion game. | Q37182267 |
| | EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. | Q37317736 |
| | Bidirectional modulation of synaptic functions by Eph/ephrin signaling. | Q37333581 |
| | Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. | Q37462557 |
| | Differential effects of overexpression of two forms of ephrin-A5 on neonatal rat cardiomyocytes | Q38294704 |
| | Evolution of tumor invasiveness: the adaptive tumor microenvironment landscape model | Q38761102 |
| | Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion. | Q39834780 |
| | EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells | Q40029434 |
| | Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. | Q40192837 |
| | Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma. | Q40463024 |
| | Expression of ephrin-B1 in hepatocellular carcinoma: possible involvement in neovascularization. | Q40612267 |
| | Identification and characterization of splice variants of ephrin-A3 and ephrin-A5. | Q40929838 |
| | Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma | Q42476586 |
| | Ephrin A5 expression promotes invasion and transformation of murine fibroblasts | Q42834761 |
| | Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer | Q43141124 |
| | Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway | Q43240643 |
| | Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis | Q45231150 |
| | Hepatitis B Virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: A Case‐Control study in Fukuoka, Japan | Q45879169 |
| | Deregulated ephrin-B2 expression in the mammary gland interferes with the development of both the glandular epithelium and vasculature and promotes metastasis formation. | Q45917197 |
| | Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time | Q46045006 |
| | EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor | Q46095419 |
| | Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis? | Q47734769 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | e41749 | |
| P577 | publication date | 2012-07-30 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma | |
| P478 | volume | 7 | |